Ludwig researchers describe how acidity turns oxygen-starved cancer cells dormant and drug resistant—and a potentially easy way reverse the effect.
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research, has potentially significant implications for cancer therapy: Large swaths of solid tumors are often deprived of oxygen, and cells in such patches are thought to be a major source of drug resistance and disease relapses.
Published today in the journal Cell, the study details how in response to acidity cells turn off a critical molecular switch known as mTORC1 that, in ordinary conditions, gauges the availability of nutrients before giving cells the green light to grow and divide. That event, Dang and his colleagues show, shuts down the cell’s production of proteins, disrupting their metabolic activity and circadian clocks, and pushing them into a quiescent state. They also demonstrate that this acid-mediated effect might be relatively easy to reverse—a finding that could help improve a variety of cancer therapies.
“In tumors grafted into mice, we see mTOR activity in spotty places where there’s oxygen,” says Dang who is also a professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute. “But if you add baking soda to the drinking water given to those mice, the entire tumor lights up with mTOR activity. The prediction would be that by reawakening these cells, you could make the tumor far more sensitive to therapy.”
Baking soda had previously been reported to enhance cancer immunotherapy by one of the co-authors of the new study, Robert Gillies of the H. Lee Moffitt Cancer Center, though the mechanism underlying the effect was unclear.
Dang’s team, including co-corresponding author Zandra Walton, an MD-PhD student at the University of Pennsylvania Perelman School of Medicine, discovered that mechanism through an intricate series of experiments done at the University of Pennsylvania and Dang’s Ludwig lab at the Wistar Institute. It centers on the behavior of lysosomes—a sack-like cellular organelle that digests proteins and that mTOR moves to when it is ready for action.
The researchers show that in acidic conditions protein motors propel lysosomes carrying mTOR away from the area around the nucleus, where they’re ordinarily located. This separates mTOR from a protein required for its activation, RHEB, which continues to hang around at that location. Lacking one of its key activation signals, mTOR remains dormant, suspending the synthesis of proteins—including the components of the cell’s molecular clock—along with most metabolic activity.
“Cells don’t want to make proteins or other biomolecules when they’re under stress,” says Dang. “They want to slow things down and only awaken when things return to normal.”
The researchers show that baking soda can reverse this effect. When given to mice in their drinking water, it surprisingly sufficed to neutralize the acidity of hypoxic patches in tumors. This sent lysosomes zipping back to the nuclear periphery in cells—where RHEB was waiting—and restored the activity of mTOR.
All this is relevant to cancer because researchers have long known that quiescent cells cannot typically be killed by chemotherapy. Notably, Dang and his team also found that T cell activation, which is essential to most immunotherapies, is similarly compromised under acidic conditions.
“We started out with a question about oxygen starvation and the circadian clock, and we ended up discovering a new mechanism by which acidic conditions in tissues shut off a lot of things—including the cell’s molecular clock,” muses Dang.
The finding that something as simple as baking soda could possibly help reverse this effect and render quiescent cancer cells susceptible to cancer therapies excites Dang.
“The concept is so easy,” he says. “It’s not some $100,000 per year drug. It’s literally just baking soda.” Dang and his team are now looking into how acidity might affect immunotherapy and further exploring the acid-induced quiescence of cancer cells.
Learn more: HOW MIGHT BAKING SODA BOOST CANCER THERAPY?
The Latest on: Cancer therapy
[google_news title=”” keyword=”cancer therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer therapy
- Can cervical cancer lead to infertility? Here’s what you need to knowon March 24, 2023 at 5:00 am
Hence, it can have a significant impact on a woman's fertility. When a woman is diagnosed with cervical cancer, she may have to undergo treatment such as surgery, radiation therapy, or chemotherapy.
- How a new radiation therapy can be a game-changer for cancer careon March 24, 2023 at 4:52 am
Radiation often makes many patients feel unwell, and the fear of side effects would keep some away from treatment. However, that is no longer the case now due to these new advanced technologies.
- Philippines 'Bracing' For Surge In Cancer Patients Seeking Treatment Over Next Two Yearson March 24, 2023 at 4:07 am
In addition to a new center, the provision of newer, but more costly, cancer medicines, such as targeted therapy and immunotherapy, would also ease the PGH's burden and speed up processes, Ignacio ...
- Improvement to one of the best cancer-killing treatments is in the pipelineon March 24, 2023 at 3:59 am
Inc. There is good reason for Breen to be optimistic about the future of cancer treatment. His company is helping create that future. More specifically, his company is working with a tri-partite — or ...
- 2023-2029 Pancreatic Cancer Treatment Drugs Market: Future Possibilities and Trendson March 24, 2023 at 2:03 am
Latest [101 Pages] “Pancreatic Cancer Treatment Drugs Market” forecast report for the period of 2023-2029 provides a detailed overview of the market trends, drivers, size, shares, and growth ...
- MVision AI gains $5.8M funding to speed cancer treatment planningon March 23, 2023 at 7:18 pm
MVision AI deploys an AI segmentation model to create more personalized cancer treatment plans and improve clinical decision-making.
- Cervical Cancer Treatment Market Share By 2031on March 23, 2023 at 3:37 pm
The "Cervical Cancer Treatment Market" study describes how the technology industry is evolving and how major and ...
- 15-Year Study Finds It’s Safe to Delay Treatment for Low-Risk Prostate Canceron March 22, 2023 at 3:50 pm
Survival rates over 15 years for low-risk prostate cancer were the same whether men chose active surveillance, radiation, or surgery.
- US FDA grants accelerated approval for Incyte's skin cancer therapyon March 22, 2023 at 11:55 am
Incyte Corp said on Wednesday its monoclonal antibody, Zynyz, has won accelerated approval from the U.S. health regulator for treating a rare and aggressive type of skin cancer in adults.
via Bing News